about
Clinical applications of fundus autofluorescence in retinal diseasePreventing diabetic retinopathy through control of systemic factorsRPE tears after pegaptanib treatment in age-related macular degeneration.The use of ultra wide field fluorescein angiography in evaluation and management of uveitis.New associations of classic acute macular neuroretinopathy.Ultra-wide-field and autofluorescence imaging of choroidal dystrophies.Peripheral polypoidal choroidal vasculopathy as a cause of peripheral exudative hemorrhagic chorioretinopathy: a report of 10 eyes.Cystoid macular edema secondary to nanoparticle albumin-bound Paclitaxel therapy.Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis)Paracentral acute middle maculopathy and acute macular neuroretinopathy.Fundus autofluorescence and photoreceptor bleaching in multiple evanescent white dot syndrome.Optical coherence tomography findings in ocular argyrosis.The pearl necklace sign: a novel spectral domain optical coherence tomography finding in exudative macular disease.Adaptive optics imaging of cone mosaic abnormalities in acute macular neuroretinopathy.OCT Angiography of Paracentral Acute Middle Maculopathy Associated With Central Retinal Artery Occlusion and Deep Capillary Ischemia.Choroidal Involvement in Acute Posterior Multifocal Placoid Pigment Epitheliopathy.Multimodal Imaging in Retinal Disease: A Consensus Definition.Mucosa-associated lymphoid tissue lymphoma with intraocular involvement.Optical Coherence Tomography Angiography in Fovea Plana.Central Retinal Vein Occlusion and Paracentral Acute Middle Maculopathy Diagnosed With En Face Optical Coherence Tomography.CONGENITAL MACROVESSEL ASSOCIATED WITH CYSTOID MACULAR EDEMA AND AN IPSILATERAL INTRACRANIAL VENOUS MALFORMATIONOPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE FOVEA IN CHILDREN BORN PRETERM.Crystalline retinopathies.Tears of the retinal pigment epithelium: an old problem in a new era.Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.Comparison of diabetic retinopathy phenotype between Latinos and Blacks.Current and future approaches in the prevention and treatment of diabetic retinopathy.A new grading system for retinal pigment epithelial tears.Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib.Anti-VEGF response in macular hemorrhage and incidence of retinal pigment epithelial tears.Multimodal imaging of pigment epithelial detachment: a guide to evaluation.Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management.Grading of posterior staphyloma with spectral-domain optical coherence tomography and correlation with macular disease.Paracentral acute middle maculopathy spectral-domain optical coherence tomography feature of deep capillary ischemia.Bilateral diffuse uveal melanocytic proliferation with multiple iris cysts.Extreme choroidal thinning in high myopia.Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study.Spectrum of Retinal Vascular Diseases Associated With Paracentral Acute Middle Maculopathy.Fundus Autofluorescence Findings in Eyes With Birdshot Chorioretinitis.BIOMARKERS OF NEOVASCULAR ACTIVITY IN AGE-RELATED MACULAR DEGENERATION USING OCT ANGIOGRAPHY.
P50
Q28075181-3769F2F2-9F18-4679-A838-AA4A29BC6490Q28166089-78AACB0C-DEEA-4D35-A0C7-EB2A7E59FAF7Q33300082-610CC4D7-EBA7-43DD-B748-9BF3FFA034DBQ33412201-E10319C1-0849-4DB9-8E2C-1404C101E150Q33425311-7B4E7E87-E797-4820-BDCC-6198FE0E8732Q33739474-41FA4749-2A02-41AB-8A94-C86A2659DAF6Q34353415-2A7ABB89-E857-4FE7-BA5C-6926702BBDEDQ34591824-E679BDD3-7D9D-4CEF-B28A-9631AC543D90Q35027435-E97F957E-D5E6-4D52-BF0C-CB2119A18A5AQ35039628-16E13527-D80C-4EA3-91A3-C8609F628E07Q35039739-0A500C7D-4E1A-487F-8BD5-874EEB3F3292Q35047647-11EABADE-666C-44BB-8046-0964EB4D26D7Q35206482-BE908C45-32BE-4CE2-9190-7A48C00A8859Q35449480-BC0A6A62-8B8D-4FE8-BB90-26ED689D1B9EQ35658360-F473D253-10A3-4475-A932-169BB136A9D9Q35885386-53F25742-9782-4D22-8F6E-BCE80F877035Q35960487-2FC1BA3A-171D-479C-A35B-1B225FE70FF6Q36012301-3DF19322-2591-438C-BEA6-7484F050869CQ36082009-9E89220A-DF62-4191-AACF-3C88FA4E38EAQ36133919-6BED604A-CA28-45FD-9337-E6741D7107D0Q36154760-BB284B22-4BA9-484C-8476-D93283385BCDQ36252401-B188E258-2586-400E-BBE9-FA5E7013882FQ36668345-462B674C-AC71-4837-80E7-8C066096CA4DQ36844667-9DC4EAF5-BA83-4B55-9732-C948128BE02AQ36865130-85A4CFD1-F53F-499C-829F-1AC36B15394BQ37206768-38C0FDE3-1126-42FA-9F12-DBFB61719C97Q37221516-9396D057-116E-4944-B1E6-2C3F95E4375AQ37748435-9DBA4FB9-4BA7-47C3-B88E-999B920F376DQ37916088-8AB6D780-75BF-446D-A317-50F99A60B072Q38114675-2CDCC38A-8E30-4ABE-860B-029129F74BA8Q38123078-7D7CA58D-6C89-4F14-8FBE-F41282C6DB8EQ38130796-2BB62D80-7F3E-4E22-A19B-3EBD23277BFDQ38169299-C9E1DF45-3062-41BB-9EF1-F88622C1B87AQ38194849-49937C66-0D15-4B95-9B7F-FCE2510667A7Q38206956-6DB0A609-0801-45CF-92EA-0B1052C1C665Q38260063-CB18E3A8-16DB-4467-A0E7-1C29E6C3826BQ38388356-4A42A9C5-0C5A-4F5F-B0CE-17221AF18164Q38409243-F9CED9CD-20CF-4721-9DB6-D91951C43D1BQ38628603-335CD639-80FB-4CA8-9A91-D018176FFF73Q38674684-1BF57E1D-FED9-4B32-B5C9-EA64F751B238
P50
name
David Sarraf
@ast
David Sarraf
@en
David Sarraf
@es
David Sarraf
@nl
type
label
David Sarraf
@ast
David Sarraf
@en
David Sarraf
@es
David Sarraf
@nl
prefLabel
David Sarraf
@ast
David Sarraf
@en
David Sarraf
@es
David Sarraf
@nl